Sunday, October 15, 2023

Süleyman Demirel Üniversitesi Tıp Fakültesi Sağlık Hizmetleri Kongresi 2023

Süleyman Demirel Üniversitesi Tıp Fakültesi 2. Uluslararası / 5. Ulusal Sağlık Hizmetleri Kongresi 02 – 04 Kasım 2023

https://www.inhsc.org/

1-PATIENT-CONTROLLED EPIDURAL ANALGESIA FOR PAIN MANAGEMENT IN ACUTE THROMBOSED HEMORRHOIDS: A NON-SURGICAL APPROACH

Assoc. Prof. Mehmet Eren Yuksel

Etlik City Hospital, Surgical Intensive Care Unit, Ankara, Türkiye

Introduction: Acute thrombosed hemorrhoids cause severe pain, necessitating effective pain management. This study explores Patient-Controlled Epidural Analgesia (PCEA) as a non-surgical solution for acute thrombosed hemorrhoids, comparing its merits and drawbacks to surgical intervention.

Purpose: This study aims to assess the feasibility and effectiveness of PCEA in managing acute thrombosed hemorrhoids as an alternative to surgical procedures.

Method: A literature review was conducted using PubMed and Google Scholar. Key search terms included "acute thrombosed hemorrhoids," "pain management," "patient-controlled epidural analgesia," and "Visual Analog Scale (VAS)."

Findings: The literature review unveiled limited studies on PCEA for acute thrombosed hemorrhoids. Nevertheless, PCEA enables patients to self-administer analgesics, providing rapid pain relief and potentially reducing the need for surgery. VAS scores indicated a notable pain reduction with PCEA.

Discussion and Conclusion: The importance of individualized pain control and potential challenges like over/undermedication, equipment complexity, and opioid-related side effects must be underscored. In conclusion, PCEA offers a non-surgical, pain-relief approach for acute thrombosed hemorrhoids, even with limited studies. Careful patient selection and proper device training are critical for optimal results.

Keywords: Patient-controlled epidural analgesia, acute thrombosed hemorrhoids, pain management, non-surgical approach, visual analog scale


2-INVESTIGATING DIVERSE CORTICOSTEROID REGIMENS IN GRANULOMATOUS MASTITIS TREATMENT

Assoc. Prof. Mehmet Eren Yuksel

Etlik City Hospital, Surgical Intensive Care Unit, Ankara, Türkiye

Introduction: Granulomatous mastitis, a rare benign breast condition, necessitates personalized corticosteroid regimens for effective management. This condition's complexity and variable clinical manifestations require a comprehensive examination of various corticosteroid treatment approaches. We explore this phenomenon by thoroughly studying the various regimens available.

Purpose: The primary aim of this study is to review and compare corticosteroid treatment regimens for granulomatous mastitis. By doing so, we aim to compare different therapy regimens in order to find a common ground and reach a universally accepted corticosteroid regimen, thus ensuring a more standardized and effective approach to treatment.

Method: Our research approach involved a comprehensive literature review, utilizing PubMed and Google Scholar to investigate various corticosteroid regimens in the treatment of granulomatous mastitis.

Findings: Prednisolone and methylprednisolone emerged as common choices. Prednisolone, often administered as 5 mg tablets, is prescribed in a reducing dose regimen over 12 days, with an initial high dose of 12 tablets on the first day. In contrast, methylprednisolone starts with an 8 mg dose in the first week, reduces to 4 mg in the second week, and further tapers to 2 mg over a 6-week period. Notably, these regimens have been successfully implemented at Gazi University School of Medicine, Department of General Surgery.

Discussion and Conclusion: The analysis of these findings underscores the importance of individualized corticosteroid regimens based on the patient's unique clinical presentation and response to therapy. These diverse approaches help manage granulomatous mastitis effectively and reduce associated symptoms. Personalized treatment regimens should be at the forefront of healthcare practices for this rare breast condition. While there is currently no universally accepted corticosteroid treatment regimen, our study emphasizes the need to work towards a consensus in order to improve patient care.

Keywords: Corticosteroids, Granulomatous Mastitis, Treatment Regimens, Personalized Care



No comments: